Laboratory Of Stock Today
| LH Stock | USD 241.16 0.99 0.41% |
Performance5 of 100
| Odds Of DistressLess than 5
|
Laboratory is trading at 241.16 as of the 30th of November 2024. This is a 0.41 percent down since the beginning of the trading day. The stock's open price was 242.15. Laboratory has under 5 % chance of experiencing financial distress over the next 2 years but had a somewhat modest performance during the last 90 days. Note, on September 2, 2024, Representative John James of US Congress acquired under $15k worth of Laboratory's common stock.
Business Domain Health Care Equipment & Services | IPO Date 29th of March 1990 | Category Healthcare | Classification Health Care |
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina. The company has 83.64 M outstanding shares of which 2.23 M shares are now sold short in the market by investors with about 2.93 days to cover all shorted shares. More on Laboratory of
Moving together with Laboratory Stock
Moving against Laboratory Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Laboratory Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO | Paul Kirchgraber | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Healthcare (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NYSE Composite, Stock Exchange Of, SET50 Index, SP 500 Index, SET100 Index, SET Total Return, Healthcare, Health Care, Health Care Providers & Services, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Excise Tax Activities | Animal Testing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsLaboratory can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Laboratory's financial leverage. It provides some insight into what part of Laboratory's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Laboratory of (LH) is traded on New York Stock Exchange in USA. It is located in 358 South Main Street, Burlington, NC, United States, 27215 and employs 67,000 people. Laboratory is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a market capitalization of 20.25 B. Laboratory is active under Health Care Providers & Services sector as part of Health Care industry. The entity has 83.64 M outstanding shares of which 2.23 M shares are now sold short in the market by investors with about 2.93 days to cover all shorted shares.
Laboratory of reports about 430 M in cash with 1.33 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.63.
Check Laboratory Probability Of Bankruptcy
Ownership AllocationLaboratory maintains a total of 83.64 Million outstanding shares. The majority of Laboratory outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Laboratory of to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Laboratory. Please pay attention to any change in the institutional holdings of Laboratory as this could imply that something significant has changed or is about to change at the company. On September 2, 2024, Representative John James of US Congress acquired under $15k worth of Laboratory's common stock.
Check Laboratory Ownership Details
Laboratory Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Dimensional Fund Advisors, Inc. | 2024-09-30 | 1.4 M | |
| Amvescap Plc. | 2024-06-30 | 1.3 M | |
| Veritas Investment Partners (uk) Ltd. | 2024-09-30 | 1.2 M | |
| Norges Bank | 6024-06-30 | 1 M | |
| Northern Trust Corp | 2024-09-30 | 1 M | |
| Nordea Investment Mgmt Bank Demark A/s | 2024-09-30 | 984 K | |
| Bank Of America Corp | 2024-06-30 | 978.1 K | |
| Cooke & Bieler Lp | 2024-09-30 | 942.1 K | |
| Ubs Asset Mgmt Americas Inc | 2024-09-30 | 914 K | |
| Vanguard Group Inc | 2024-09-30 | 9.6 M | |
| Blackrock Inc | 2024-06-30 | 9.5 M |
Laboratory Historical Income Statement
Laboratory Stock Against Markets
Laboratory Corporate Directors
| Kerrii Anderson | Independent Director | Profile | |
| JeanLuc Belingard | Independent Director | Profile | |
| Peter Neupert | Lead Independent Director | Profile | |
| Richelle Parham | Independent Director | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 2.88 | Earnings Share 5.28 | Revenue Per Share 151.028 | Quarterly Revenue Growth 0.074 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.